undamentalytics Newsletter
Sign in

Quidelortho Corp cash flow statement

In fiscal 2025, Quidelortho Corp's operations generated $105m of cash; it spent $188m on capital projects, leaving free cash flow of −$83.0m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Jan 20212021Jan 20222022Jan 20232023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations63080688528083105−57
Depreciation and amortisation4953284457453442454
Stock-based pay21254852424644
Capital spending65293141209195188154
Free cash flow56551374471−112−83−211
Free cash flow after stock pay54448869619−154−129−256
Share buybacks4410474700—
Shares issued1082612565

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: QDEL vs RVTYPODD vs QDELENOV vs QDELGMED vs QDEL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Quidelortho Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Quidelortho Corp.